Article
Albumin-binding Aptamer Chimeras for Improved siRNA Bioavailability
2021-04-16
Abstract excerpt
Short interfering RNAs (siRNAs) are potent nucleic acid-based drugs designed to target disease driving genes that may otherwise be undruggable with small molecules. However, the potential of administering therapeutic siRNA in vivo is limited by poor pharmacokinetic properties, including rapid renal clearance and nuclease degradation. Nanocarriers have traditionally been explored as means to overcome these challen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 61736a7f-1a36-585a-bc94-9caaea953d3c
- DOI
- 10.1101/2021.04.15.440012
